Last updated: Nov 20, 2026, 12:00 AM

Bicara Therapeutics Inc. Common Stock Exchange (NASDAQ, USD)

BCAX

8.44
-0.27 (-2.69%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
-31.63%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
645.19M
Price/Sales
-
Ent value
592.06M
Price/Book
1.38
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open9.87
Daily high10.17
Daily low9.55
Daily Volume1.10M
All-time high30.40
1y analyst estimate33.92
Beta-0.34
EPS (TTM)-2.73
Dividend per share0.00
Ex-div date-
Next earnings date26 Mar 2026

Ready to capitalize on Bicara Therapeutics Inc. Common Stock's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
BCAXS&P500
Current price drop from All-time high-72.24%-11.46%
Highest price drop-73.91%-56.47%
Date of highest drop2 Nov 20269 Mar 2009
Avg drop from high-37.29%-10.64%
Avg time to new high78 days12 days
Max time to new high445 days1805 days